Zimmer Biomet Holdings Management
Management criteria checks 3/4
Zimmer Biomet Holdings' CEO is Ivan Tornos, appointed in Mar 2021, has a tenure of 3.67 years. total yearly compensation is $10.19M, comprised of 9.5% salary and 90.5% bonuses, including company stock and options. directly owns 0.013% of the company’s shares, worth $2.95M. The average tenure of the management team and the board of directors is 3.7 years and 6.3 years respectively.
Key information
Ivan Tornos
Chief executive officer
US$10.2m
Total compensation
| CEO salary percentage | 9.5% |
| CEO tenure | 3.7yrs |
| CEO ownership | 0.01% |
| Management average tenure | 3.7yrs |
| Board average tenure | 6.3yrs |
Recent management updates
Recent updates
Shareholders Can Be Confident That Zimmer Biomet Holdings' (NYSE:ZBH) Earnings Are High Quality
Nov 07
Results: Zimmer Biomet Holdings, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
Nov 02Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Share Price Not Quite Adding Up
Oct 03Zimmer Biomet: The Undervalued Titan Of Joint Replacements
Oct 02Zimmer Biomet Stock: Don't Jump In At The 52-Week Low
Sep 19We Like These Underlying Return On Capital Trends At Zimmer Biomet Holdings (NYSE:ZBH)
Sep 18Zimmer Biomet Holdings (NYSE:ZBH) Is Due To Pay A Dividend Of $0.24
Sep 02Zimmer Biomet Holdings (NYSE:ZBH) Seems To Use Debt Quite Sensibly
Aug 27Are Investors Undervaluing Zimmer Biomet Holdings, Inc. (NYSE:ZBH) By 45%?
Jul 15Investors Interested In Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Earnings
Jul 02Zimmer Biomet: Brighter Prospects In H2 2024
Jul 02Zimmer Biomet Holdings (NYSE:ZBH) Has Affirmed Its Dividend Of $0.24
Jun 19When Should You Buy Zimmer Biomet Holdings, Inc. (NYSE:ZBH)?
Jun 05Zimmer Biomet Holdings' (NYSE:ZBH) Dividend Will Be $0.24
May 21Zimmer Biomet Holdings: Moving Along
May 17The Return Trends At Zimmer Biomet Holdings (NYSE:ZBH) Look Promising
May 02Is Zimmer Biomet Holdings (NYSE:ZBH) Using Too Much Debt?
Mar 20Zimmer Biomet Holdings (NYSE:ZBH) Will Pay A Dividend Of $0.24
Mar 02Zimmer Biomet Holdings' (NYSE:ZBH) Strong Earnings Are Of Good Quality
Feb 15What Does Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Share Price Indicate?
Feb 11Zimmer Biomet: Weight Loss Drug Concerns Are Overblown
Feb 05A Look At The Fair Value Of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
Jan 29Zimmer Biomet: Growth Acceleration Is Likely Driven By ROSA; Initiate With 'Buy'
Jan 20Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Not Flying Under The Radar
Jan 15The Returns At Zimmer Biomet Holdings (NYSE:ZBH) Aren't Growing
Dec 31Zimmer Biomet Holdings: Visible Growth Drivers And Strong Execution
Dec 18Here's Why Zimmer Biomet Holdings (NYSE:ZBH) Can Manage Its Debt Responsibly
Dec 17Zimmer Biomet: Still Many Questions After A Solid Year So Far
Nov 26When Should You Buy Zimmer Biomet Holdings, Inc. (NYSE:ZBH)?
Nov 06Here's Why We Think Zimmer Biomet Holdings (NYSE:ZBH) Is Well Worth Watching
Oct 07Returns On Capital At Zimmer Biomet Holdings (NYSE:ZBH) Have Hit The Brakes
Sep 21Zimmer Biomet Holdings: Growth Strategies For 2023 Instill Confidence
Sep 14Calculating The Intrinsic Value Of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
Sep 06Zimmer Biomet: Guidance Raise, Better Margins In 2024 Make It A Buy
Aug 11Is Zimmer Biomet Holdings (NYSE:ZBH) A Risky Investment?
Aug 08Should You Think About Buying Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Now?
Jul 10We Ran A Stock Scan For Earnings Growth And Zimmer Biomet Holdings (NYSE:ZBH) Passed With Ease
Jun 27Slowing Rates Of Return At Zimmer Biomet Holdings (NYSE:ZBH) Leave Little Room For Excitement
Jun 13A Look At The Fair Value Of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
May 30Zimmer Biomet: Expect Growth Momentum To Continue
May 26Is Zimmer Biomet Holdings (NYSE:ZBH) Using Too Much Debt?
May 04CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$1b |
| Jun 30 2024 | n/a | n/a | US$997m |
| Mar 31 2024 | n/a | n/a | US$964m |
| Dec 31 2023 | US$10m | US$969k | US$1b |
| Sep 30 2023 | n/a | n/a | US$474m |
| Jun 30 2023 | n/a | n/a | US$506m |
| Mar 31 2023 | n/a | n/a | US$450m |
| Dec 31 2022 | US$6m | US$823k | US$290m |
| Sep 30 2022 | n/a | n/a | US$366m |
| Jun 30 2022 | n/a | n/a | US$334m |
| Mar 31 2022 | n/a | n/a | US$325m |
| Dec 31 2021 | US$5m | US$731k | US$445m |
| Sep 30 2021 | n/a | n/a | US$834m |
| Jun 30 2021 | n/a | n/a | US$914m |
| Mar 31 2021 | n/a | n/a | US$563m |
| Dec 31 2020 | US$4m | US$730k | -US$11m |
| Sep 30 2020 | n/a | n/a | -US$152m |
| Jun 30 2020 | n/a | n/a | US$37m |
| Mar 31 2020 | n/a | n/a | US$377m |
| Dec 31 2019 | US$4m | US$700k | US$1b |
| Sep 30 2019 | n/a | n/a | -US$90m |
| Jun 30 2019 | n/a | n/a | -US$359m |
| Mar 31 2019 | n/a | n/a | -US$308m |
| Dec 31 2018 | US$4m | US$113k | -US$379m |
Compensation vs Market: Ivan's total compensation ($USD10.19M) is about average for companies of similar size in the US market ($USD12.67M).
Compensation vs Earnings: Ivan's compensation has increased by more than 20% in the past year.
CEO
Ivan Tornos (49 yo)
3.7yrs
Tenure
US$10,191,476
Compensation
Mr. Ivan Tornos serves as Independent External Director at PHC Holdings Corporation since September 03, 2021. He joined PHC Holdings Corporation on September 03, 2021. Mr. Tornos serves as Chief Operating...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| COO, President | 3.7yrs | US$10.19m | 0.013% $ 2.9m | |
| CFO and Executive VP of Finance | 5.3yrs | US$10.38m | 0.015% $ 3.3m | |
| Senior VP | 17.5yrs | US$2.87m | 0.025% $ 5.4m | |
| President of Asia Pacific | 9.4yrs | US$3.38m | 0.0027% $ 585.8k | |
| Group President of Europe | 3.4yrs | US$3.42m | 0.0046% $ 1.0m | |
| VP, Controller & Chief Accounting Officer | 2.5yrs | no data | 0.00069% $ 151.4k | |
| Senior VP & Chief Information and Technology Officer | less than a year | no data | no data | |
| Senior VP & Chief Administrative Officer | less than a year | no data | 0.0034% $ 754.7k | |
| Senior VP of Investor Relations | less than a year | no data | no data | |
| Senior VP | 9.4yrs | no data | no data | |
| Senior VP & Chief Human Resources Officer | 3.8yrs | no data | 0.0017% $ 368.6k | |
| Senior Vice President of Global Quality & Regulatory Affairs | 7.3yrs | no data | no data |
3.7yrs
Average Tenure
54yo
Average Age
Experienced Management: ZBH's management team is considered experienced (3.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| COO, President | 1.3yrs | US$10.19m | 0.013% $ 2.9m | |
| Independent Chairman of the Board | 12.3yrs | US$409.38k | 0.0018% $ 390.5k | |
| Independent Director | 15.8yrs | US$340.26k | 0.0027% $ 581.4k | |
| Independent Director | 16.7yrs | US$358.20k | 0.0020% $ 441.0k | |
| Independent Director | 17.8yrs | US$347.75k | 0.0017% $ 375.1k | |
| Director | less than a year | no data | no data | |
| Independent Director | 6.3yrs | US$314.44k | 0.00083% $ 182.1k | |
| Independent Director | 9.9yrs | US$342.52k | 0.0010% $ 219.4k | |
| Director | less than a year | no data | no data | |
| Independent Director | 3.8yrs | US$382.35k | 0.00050% $ 109.7k | |
| Independent Director | 6.3yrs | US$367.52k | 0.0020% $ 447.5k |
6.3yrs
Average Tenure
60yo
Average Age
Experienced Board: ZBH's board of directors are considered experienced (6.3 years average tenure).